166 related articles for article (PubMed ID: 11679846)
21. Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma.
Kitagawa Y; Nishizawa S; Sano K; Ogasawara T; Nakamura M; Sadato N; Yoshida M; Yonekura Y
J Nucl Med; 2003 Feb; 44(2):198-206. PubMed ID: 12571209
[TBL] [Abstract][Full Text] [Related]
22. A head and neck radiologist's perspective on best practices for the usage of PET/CT scans for the diagnosis and treatment of head and neck cancers.
Zollinger LV; Wiggins RH
Arch Otolaryngol Head Neck Surg; 2012 Aug; 138(8):754-8. PubMed ID: 22911298
[No Abstract] [Full Text] [Related]
23. The role of post-radiation therapy FDG PET in prediction of necessity for post-radiation therapy neck dissection in locally advanced head-and-neck squamous cell carcinoma.
Yao M; Graham MM; Hoffman HT; Smith RB; Funk GF; Graham SM; Dornfeld KJ; Skwarchuk M; Menda Y; Buatti JM
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1001-10. PubMed ID: 15234033
[TBL] [Abstract][Full Text] [Related]
24. Role of positron emission tomography/computed tomography (PET/CT) in head and neck cancer.
Escott EJ
Radiol Clin North Am; 2013 Sep; 51(5):881-93. PubMed ID: 24010911
[TBL] [Abstract][Full Text] [Related]
25. Value of FDG PET in assessment of treatment response and surveillance in head-and-neck cancer patients after intensity modulated radiation treatment: a preliminary report.
Yao M; Graham MM; Smith RB; Dornfeld KJ; Skwarchuk M; Hoffman HT; Funk GF; Graham SM; Menda Y; Buatti JM
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1410-8. PubMed ID: 15590172
[TBL] [Abstract][Full Text] [Related]
26. Can positron emission tomography improve the quality of care for head-and-neck cancer patients?
Schechter NR; Gillenwater AM; Byers RM; Garden AS; Morrison WH; Nguyen LN; Podoloff DA; Ang KK
Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):4-9. PubMed ID: 11516844
[TBL] [Abstract][Full Text] [Related]
27. Positron emission tomography in cancer of the head and neck.
Hain SF
Br J Oral Maxillofac Surg; 2005 Feb; 43(1):1-6. PubMed ID: 15620766
[TBL] [Abstract][Full Text] [Related]
28. The role of FDG PET in management of neck metastasis from head-and-neck cancer after definitive radiation treatment.
Yao M; Smith RB; Graham MM; Hoffman HT; Tan H; Funk GF; Graham SM; Chang K; Dornfeld KJ; Menda Y; Buatti JM
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):991-9. PubMed ID: 16099601
[TBL] [Abstract][Full Text] [Related]
29. [[F-18]FDG imaging of head and neck tumors: comparison of hybrid PET, dedicated PET and CT].
Dresel S; Schwenzer K; Brinkbäumer K; Schmid R; Szeimies U; Pöpperl G; Hahn K
Nuklearmedizin; 2001 Oct; 40(5):172-8. PubMed ID: 11727630
[TBL] [Abstract][Full Text] [Related]
30. Role of 11-C-methionine positron emission tomography for the delineation of the tumor volume in pharyngo-laryngeal squamous cell carcinoma: comparison with FDG-PET and CT.
Geets X; Daisne JF; Gregoire V; Hamoir M; Lonneux M
Radiother Oncol; 2004 Jun; 71(3):267-73. PubMed ID: 15172141
[TBL] [Abstract][Full Text] [Related]
31. [Positron emission tomography in head and neck oncology].
Foehrenbach H; Conessa C; Maszelin P; Kossowski M; Poncet JL; Gaillard JF
Ann Otolaryngol Chir Cervicofac; 2001 Dec; 118(6):365-72. PubMed ID: 11908338
[TBL] [Abstract][Full Text] [Related]
32. Role of PET FDG in the management of head and neck squamous cell cancer.
Wong WL; Saunders M
Clin Oncol (R Coll Radiol); 1998; 10(6):361-6. PubMed ID: 9890536
[No Abstract] [Full Text] [Related]
33. [Diagnostic value of 18F-fDG Pet/CT in the detection of the cervical lymph nodes metastasis].
Ke Z; Liu M; Liu Y; He Z; Zhang Y; Zhang W
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Mar; 20(6):243-5. PubMed ID: 16739373
[TBL] [Abstract][Full Text] [Related]
34. [Positron emission tomography for primary tumor detection in lymph node metastases with unknown primary tumor].
Schipper JH; Schrader M; Arweiler D; Müller S; Sciuk J
HNO; 1996 May; 44(5):254-7. PubMed ID: 8707630
[TBL] [Abstract][Full Text] [Related]
35. Dual modality of 18F-fluorodeoxyglucose-positron emission tomography/computed tomography in patients with cervical carcinoma of unknown primary.
Freudenberg LS; Fischer M; Antoch G; Jentzen W; Gutzeit A; Rosenbaum SJ; Bockisch A; Egelhof T
Med Princ Pract; 2005; 14(3):155-60. PubMed ID: 15863988
[TBL] [Abstract][Full Text] [Related]
36. [Current applications and future developments of positron emission tomography in head and neck cancer].
Lonneux M
Cancer Radiother; 2005 Feb; 9(1):8-15. PubMed ID: 15804615
[TBL] [Abstract][Full Text] [Related]
37. F-18-fluoro-deoxy-glucose positron-emission tomography scanning in detection of local recurrence after radiotherapy for laryngeal/ pharyngeal cancer.
Terhaard CH; Bongers V; van Rijk PP; Hordijk GJ
Head Neck; 2001 Nov; 23(11):933-41. PubMed ID: 11754496
[TBL] [Abstract][Full Text] [Related]
38. PET in face and neck tumours.
Rankin SC
Cancer Imaging; 2006 Oct; 6(Spec No A):S89-95. PubMed ID: 17114083
[TBL] [Abstract][Full Text] [Related]
39. FDG PET in head and neck cancer.
Keyes JW; Watson NE; Williams DW; Greven KM; McGuirt WF
AJR Am J Roentgenol; 1997 Dec; 169(6):1663-9. PubMed ID: 9393187
[TBL] [Abstract][Full Text] [Related]
40. 18F-FLT PET does not discriminate between reactive and metastatic lymph nodes in primary head and neck cancer patients.
Troost EG; Vogel WV; Merkx MA; Slootweg PJ; Marres HA; Peeters WJ; Bussink J; van der Kogel AJ; Oyen WJ; Kaanders JH
J Nucl Med; 2007 May; 48(5):726-35. PubMed ID: 17475960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]